Unprecedented mode of action of phenothiazines as ionophores unravelled by an NDH-2 bioelectrochemical assay platform by Nakatani, Y et al.
This is a repository copy of Unprecedented mode of action of phenothiazines as 
ionophores unravelled by an NDH-2 bioelectrochemical assay platform.




Nakatani, Y, Shimaki, Y, Debajyoti, D et al. (4 more authors) (2020) Unprecedented mode 
of action of phenothiazines as ionophores unravelled by an NDH-2 bioelectrochemical 
assay platform. Journal of the American Chemical Society, 142 (3). pp. 1311-1320. ISSN 
0002-7863 
https://doi.org/10.1021/jacs.9b10254
© 2019 American Chemical Society. This is an author produced version of a paper 





Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by White Rose Research Online
This document is confidential and is proprietary to the American Chemical Society and its authors. Do not 
copy or disclose without written permission. If you have received this item in error, notify the sender and 
delete all copies.
Unprecedented mode of action of phenothiazines as 
ionophores unravelled by an NDH-2 bioelectrochemical 
assay platform
Journal: Journal of the American Chemical Society
Manuscript ID ja-2019-10254c.R2
Manuscript Type: Article
Date Submitted by the 
Author:
17-Dec-2019
Complete List of Authors: Nakatani, Yoshio; University of Otago, Microbiology and Immunology
Shimaki, Yosuke; University of Otago, Microbiology and Immunology
Dutta, Debajyoti; University of Leeds, Faculty of Biological Sciences
Muench, Stephen; University of Leeds, School of Biomedical Sciences
Ireton, Keith; University of Otago, Microbiology and Immunology
Cook, Gregory; University of Otago
Jeuken, Lars; University of Leeds, School of Biomedical Sciences, the 
Astbu
 
ACS Paragon Plus Environment
Journal of the American Chemical Society
Unprecedented properties of phenothiazines unraveled by a NDH-2 
bioelectrochemical assay platform
Yoshio Nakatani1,2‡*, Yosuke Shimaki1‡, Debajyoti Dutta3, Stephen P. Muench3, Keith Ireton1, 
Gregory M. Cook1,2, Lars J. C. Jeuken3*
1. Department of Microbiology and Immunology, University of Otago, Dunedin 9054, New 
Zealand
2. Maurice Wilkins Centre for Molecular Biodiscovery, The University of Auckland, Private 
Bag 92019, Auckland 1042, New Zealand
3. School of Biomedical Sciences and the Astbury Centre for Structural Molecular Biology, 
University of Leeds, Leeds LS2 9JT, United Kingdom 
‡These authors contributed equally.
*Authors for correspondence: Yoshio Nakatani (yoshio.nakatani@otago.ac.nz) and Lars J. C. 
Jeuken (L.J.C.Jeuken@leeds.ac.uk)
Page 1 of 29
ACS Paragon Plus Environment






























































Type II NADH:quinone oxidoreductase (NDH-2) plays a crucial role in the respiratory chains 
of many organisms. Its absence in mammalian cells makes NDH-2 an attractive new target for 
developing antimicrobials and anti-protozoal agents. We established a novel 
bioelectrochemical platform to characterize the catalytic behavior of NDH-2 from 
Caldalkalibacillus thermarum and Listeria monocytogenes strain EGD-e while bound to 
native-like lipid membranes. Catalysis of both NADH oxidation and lipophilic quinone 
reduction by membrane-bound NDH-2 followed the Michaelis–Menten model; however, the 
maximum turnover was only achieved when a high concentration of quinone (>3 mM) was 
present in the membrane, suggesting that quinone availability regulates NADH-coupled 
respiration activity. The quinone analogue 2-heptyl-4-hydroxyquinoline-N-oxide inhibited C. 
thermarum NDH-2 activity and its potency is higher in a membrane environment compared to 
assays performed with water-soluble quinone analogues, demonstrating the importance of 
testing compounds under physiologically relevant conditions. Furthermore, when 
phenothiazines, one of the most commonly identified NDH-2 inhibitors, were tested, they did 
not inhibit membrane-bound NDH-2. Instead, our assay platform unexpectedly suggests a 
novel mode of phenothiazine action where chlorpromazine, a promising anti-tubercular agent 
and key medicine used to treat psychotic disorders, is able to disrupt pH gradients across 
bacterial membranes.
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NADH dehydrogenase/NADH:quinone oxidoreductase (NDH) is a key respiratory enzyme in 
many organisms. This class of enzymes catalyzes oxidation of NADH and reduction of quinone, 
and plays a crucial role in maintaining the cellular NAD+/NADH balance and serves as a 
primary electron entry point for the respiratory chain to drive ATP synthesis. Type II 
NADH:quinone oxidoreductase (NDH-2) is a 40–70 kDa single subunit monotopic membrane 
protein distinct from two other functionally related NDHs—the proton pumping type NDH 
(NDH-I/complex I) and the sodium pumping type NDH (NQR).1,2 NDH-2 has two Rossmann 
fold domains linked to the non-conserved C-terminal membrane-anchoring domain.3-6 
Nucleotide binding domains are exposed to the cytosol and responsible for binding NADH and 
hosting flavin co-factors FAD/FMN, whereas the quinone-binding site (Q-site) is located at the 
C-terminal domain proposed to face the lipid membrane.5-7 The FAD isoalloxazine is midway 
between the NADH binding site and Q-site, and is the catalytic center of NDH-2 where 
exergonic reactions of NADH oxidation and quinone reduction take place.8 Because of its 
structural and catalytic simplicity, NDH-2 does not transfer protons across the membrane and 
does not directly contribute to generation of proton motive force.8 This might be advantageous 
for some organisms in the maintenance of the NAD+/NADH redox balance and generation of 
ATP because its catalytic function cannot be compromised by proton motive force back-
pressure.
The ndh-2 gene has been identified in a wide range of organisms ranging from bacteria, fungi, 
protists and plants but not in any mammals,4 which makes it an attractive target for 
antimicrobial development. Iodonium derivatives,9,10 flavones,11,12 quinolones,13-21 
phenothiazines,11,22,23 and nanaomycin A and polymyxin B24,25 have been identified as NDH-
2 inhibitors with moderate activities. Among them, quinolones and phenothiazines are the most 
commonly identified NDH-2 inhibitors for many species, and quinolones, represented by 2-
heptyl-4-hydroxyquinoline-N-oxide (HQNO), have the best biochemical and structural 
validation.26 Their quinolone bicyclic core structure mimics a menaquinone head group. In 
bacterial and yeast NDH-2 quinolone complex structures, the head groups of HQNO and AC0-
12 bind next to the si face of the FAD prosthetic group at the Q-site, blocking quinone 
access.26,27 Since the discovery of their anti-tubercular activities, phenothiazines have been 
regarded as promising compounds for development of new antimicrobials.28 However, the 
molecular inhibition mechanism of phenothiazines remains unclear despite their inhibitory 
activity against many NDH-2s. After discovery of the ndh-2 gene essentiality in survival of the 
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important pathogens Mycobacterium tuberculosis29,30 and Plasmodium falciparum,9,16 several 
major anti-tubercular and -malarial drug development programs have been pursued by 
academia and industry, and potent (low nanomolar inhibition activity) quinolone and 
quinolinyl pyrimidine derivatives have been developed through medicinal chemistry 
approaches.14,15,31 However, to date, there has been little success in the development of drugs 
targeting NDH-2. One major impediment to rationale development of NDH-2 therapeutics is a 
lack of understanding of the inhibition mechanisms.
Knowledge of the molecular structure and catalytic mechanism of NDH-2 is essential for 
development of new therapeutics against NDH-2, but these have just started being uncovered 
despite over half a century of NDH-2 research. Early on, NDH-2 research relied on membrane 
extracts, which have little NDH-2 activity. Even after establishing heterologous over-
expression systems for NDH-2, extracting and purifying highly active NDH-2s from 
membranes using detergents remains challenging. Screening compounds using membrane 
extracts or materials with low activity might result in failure to identify promising hits and 
improve the specificity of NDH-2 inhibitors. Until now, only six highly active NDH-2s 
(turnover rates (kcat) in the range of 580–1500 s−1) have been reported from Saccharomyces 
cerevisiae,27 Caldalkalibacillus thermarum,8 Staphylococcus aureus,23 Plasmodium 
falciparum,32 Mycobacterium tuberculosis,33 and Streptococcus agalactiae.34 Importantly, 
crystal structures for all these NDH-2s, except those from M. tuberculosis and S. agalactiae, 
have been determined.5,6,13,32 The use of highly stable and active NDH-2 has allowed us to 
unambiguously unravel its catalytic mechanism.8
We have previously developed a bioelectrochemical system coupled with a tethered bilayer 
lipid membrane to study respiratory enzyme behavior in a native-like environment.35,36 This 
sensitive analytical method can detect catalytic activity in membrane extracts or purified 
respiratory enzymes.35,37,38 Such a system is ideal to characterize “difficult membrane proteins” 
like NDH-2. Here, we developed a novel NDH-2 bioelectrochemical platform (Figure 1A) and 
analyzed catalysis of the membrane-bound C. thermarum NDH-2. Validation of NDH-2 
inhibitors and elucidation of their modes of action in membranes uncovered some unexpected 
behaviors of phenothiazines. Furthermore, we adapted our bioelectrochemical platform to 
study NDH-2 from Listeria monocytogenes, showing its superiority over conventional 
biochemical assays that requires a very small amount of NDH-2 for kinetic characterization 
and inhibitor tests.
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Establishing a new NDH-2 bioelectrochemical assay platform
Impedance spectroscopy confirmed that planar membranes containing C. thermarum NDH-2 
spontaneously formed after applying a solution of Escherichia coli polar lipid proteoliposomes, 
pre-mixed with purified C. thermarum NDH-2, onto an electrode with a self-assembled 
monolayer containing cholesterol “tethers” (Figure 1B).35 The E. coli polar lipids were 
supplemented by menaquinone-7 (MK-7). Cyclic voltammetry (CV) was used to characterize 
kinetics by monitoring quinone reduction activity, which is directly visible as catalytic currents. 
Figure 2A (blue trace) shows a CV in the absence of NADH where a MK-7 oxidation peak is 
visible at ~0.15 V versus standard hydrogen electrode (SHE) and the corresponding reduction 
peak at ~–0.3 V. Small UQ-8 reduction and oxidation signals are also visible at approximately 
–0.1 and 0.35 V, respectively. UQ-8 is naturally present in the E. coli lipid extract used to make 
the membrane-coated electrodes.35 Addition of NADH produced a sigmoidal CV trace with the 
same onset as MK-7 oxidation, confirming NADH:MK-7 oxidoreduction activity. Activity of 
the membrane-bound C. thermarum NDH-2 followed a Michaelis–Menten model (Figures 2A–
C and S1A), consistent with our reported in-solution assay results.8 We did not observe unusual 
catalytic behaviors such as an allosteric mechanism as proposed for P. falciparum NDH-232 or 
the two quinone-binding model that was proposed by Godoy-Hernandez et al. (which was 
reported during the peer-review process of this article).39 The estimated KMNADH of 8.6 M was 
slightly lower than but comparable to the KMNADH of the in-solution assay (29 M). By contrast, 
the KMMK-7 was two orders of magnitudes higher (3.2 mM) than that of the in-solution assay 
(KMMenadione = 34 M). We previously observed similar behavior of the KMUbiquinone-10 of a 
ubiquinol oxidase.37 The high KMMK-7 suggests that lipophilic quinone transfer between the 
NDH-2 Q-site and the quinone-pool in the membrane environment is slow and the quinone 
concentration can become a rate-limiting step. The maximum turnover rate was approximately 
1.9–2.0 A cm−2 (Figures 2B and 2C). Based on the protein-to-lipid ratio used, we estimate a 
surface coverage of C. thermarum NDH-2 in the order of 20-40 fmol cm-2, resulting in an 
estimated kcat (250–600 s−1) at 20C, slightly lower than the in-solution kcat which was 
measured at the higher temperature of at 37C (1190 s−1) in the previous study.8 NADPH 
titration confirmed the low binding affinity of NADPH (KMNADPH of 367.4 M, Figures 2D and 
S1B), which was consistent with a previous result.8 The maximum turnover rate was lower (1.4 
A cm−2). After washing the electrochemical cell, addition of NADH restored the rate close to 
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2.0 A cm−2 (Figures 2D, S1B and S1C). This example highlights the reproducibility and 
versatility of our NDH-2 electrochemical platform.
To further validate our system, we tested nucleotide-binding and Q-site mutants.8 G164E and 
I379E NDH-2 variants have ablated binding ability to either NADH or the water-soluble 
quinone menadione (MD), respectively.8 Figures 2E and 2F show drastic reductions in the 
turnover rates for both mutants. G164E and I379E NDH-2 variants showed only 2.8% and 
6.3% of wild-type activity (at 200 M NADH), respectively (Figures 2E, 2F, S1D and S1E). 
The KMNADH of the G164E mutant could not be determined but the calculated KMNADH of the 
Q-site mutant (I379E) was 1.3 M. This lower KMNADH compared to the wild-type most likely 
represents the capping effect observed in the previous study.8 Notably, the Q-site mutant 
showed a greater reduction in activity in the membrane (94% reduction, compare Figure 2F to 
Figure 2B) than in solution (~50%).8 This suggests that the I379E mutation is structurally more 
significant in a membrane environment and causes more adverse effects against lipophilic 
quinone binding. 
Evaluating NDH-2 inhibitors using the new NDH-2 bioelectrochemical assay platform
Proposed NDH-2 inhibitors, including HQNO and three phenothiazines (chlorpromazine 
(CPZ), trifluoperazine (TPZ), and thioridazine (THZ), Figure 3A) were tested against C. 
thermarum NDH-2. HQNO inhibited C. thermarum NDH-2 with an IC50 of 6.8 M (Figures 
3B and 3C), similar to that for the in-solution assay (7.3 M).26 This was somewhat surprising 
since a large excess of quinone is present in the membrane (> 3–7 mM), compared with MD 
in the in-solution assay (50 M).26 This suggests that the HQNO binding affinity to C. 
thermarum NDH-2 in the membrane greatly increases and efficiently blocks quinone access to 
the Q-site. Washing the cell restored activity to ~50%, which suggested that HQNO remains 
in the membrane causing NDH-2 inhibition (Figure S2A). Interestingly, we discovered that 
phenothiazines were largely ineffective at inhibiting C. thermarum NDH-2 (Figures 3D, 3E, 
S2B and S2C). These results were unexpected given that TPZ and THZ inhibited detergent-
purified C. thermarum NDH-2 in the presence of Coenzyme Q2 (ubiquinone-2, UQ-2) in a 
previous study.6 Therefore, we performed additional in-solution assays and electrochemical 
experiments, which confirmed that phenothiazines were largely ineffective against NDH-2. 
First, TPZ and THZ did not show significant inhibition when measuring activity in solution 
with MD (Figure S2D). Second, our electrochemical assay confirmed CPZ also did not inhibit 
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membrane-bound C. thermarum NDH-2 in the presence of ubiquinone-10 (Figures S2E and 
S2F). It is unclear why TPZ and THZ previously inhibited C. thermarum NDH-2 activity in 
the presence of UQ-2; however, we propose that the membrane environment in the 
electrochemical platform better represents the natural physiological environment of NDH-2 
than the solution/UQ-2 assay used previously. 
Although there was very little NDH-2 inhibition by phenothiazines, we noticed that these 
compounds caused the catalytic waves to shift to different degrees (Figures 3D, S2B and S2C). 
Without NADH, shifts of MK-7 oxidation and reduction peaks were also clearly observed 
(Figure 4A). Furthermore, redox peaks of a minor fraction of UQ-8 shift to similar degree 
(Figure 4A). Importantly, the potential difference between the quinone oxidation and reduction 
peaks decreased. We previously observed a very similar effect when a protonophore, carbonyl 
cyanide m-chlorophenyl hydrazone (CCCP) was added to the membrane-modified electrodes 
and this was shown to be caused by an enhancement in proton mobility through the membrane 
which aids the (de)protonation of the lipophilic quinones that is coupled to their 
oxidation/reduction.38 Taken together these observations suggest CPZ acts as a protonophore. 
Impedance spectroscopy was performed to confirm this hypothesis. Indeed, in the Bode plot 
(Figure 4B) a large drop in phase is observed below 10 Hz upon addition of CPZ, which is 
characteristic of reduction in membrane resistance (increase in membrane permeability) and 
thus consistent with an ionophore effect.35,40 Additionally, we performed solution assays with 
liposomes encapsulating 8-hydroxypyrene-1,3,6-trisulfonic acid (HPTS) as a fluorescent pH 
probe. After changing the pH on the outside of the liposomes, protons were observed to leak 
into the liposomes and slowly equilibrated (Figure 4C). As expected, further addition of 
gramicidin, a powerful ionophore, resulted in immediate pH equilibration. By contrast, adding 
CPZ caused a large increase in the lumen pH, followed by faster pH re-equilibration. We 
speculated this is caused by the tertiary amine of CPZ, which has a pKa of 9.3. CPZ would 
initially crosses the membrane in a neutral form (non-protonated) and then picks up a proton 
in the lumen of the liposome, rapidly increasing the pH. Then, in a slower process, CPZ seems 
to act as a protonophore, increasing the rate of pH equilibration. The protonophore activity 
could be attributed to the fact that CPZ-H+ is still able to traverse the membrane, although at a 
much slower rate than CPZ. These unexpected findings in CPZ chemical properties might have 
implications in other biological membrane systems. CPZ is a key medicine in the World Health 
Organization Model List of Essential Medicines and is used to treat psychotic disorders.41 CPZ 
affects a number of receptors in the human nervous system, including dopamine, serotonin, 
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histamine, adrenergic, and muscarinic acetylcholine receptors, but its molecular effects on the 
nervous system remain largely unknown.42 Further testing of CPZ is of interest to see if it 
shows a similar effect against mammalian membranes and the human nervous system.
Characterization of Listeria monocytogenes EGD-e NDH-2a using a bioelectrochemical 
NDH-2 assay platform.
Next, we adapted our bioelectrochemical NDH-2 system to characterize a Listeria NDH-2 
enzyme. A foodborne pathogen, Listeria monocytogenes strain EGD-e possesses two ndh-2 
genes (lmo2389 and 2638 designated as ndh-2a and -2b, respectively). Because NDH-2a is an 
important enzyme for aerobic and intracellular growth of L. monocytogenes,43 we prioritized 
characterization of NDH-2a. Despite high amino acid sequence similarity to C. thermarum 
NDH-2 (54% and 72% identity and similarity, respectively; Figure S3A), detergent-purified 
Listeria NDH-2a was unstable and difficult to purify. Thus, we used styrene maleic anhydride 
(SMA) polymer44 to purify Listeria NDH-2a (Figure S3B) with ~150 g of SMA-purified 
NDH-2a obtained from a 3-L culture. However, because only a small proportion (< 5%) of the 
purified sample contained FAD (UV-Vis analysis), conventional biochemical characterization 
was not possible. We used SMA-purified Listeria NDH-2a to create proteoliposomes and 
applied these to the self-assembled monolayer-coated gold electrode. Impedance spectroscopy 
again confirmed that the membrane-coated electrode formed immediately (Figure 5A). The 
estimated KMNADH of Listeria NDH-2a is 14.8 M and comparable to that of C. thermarum 
NDH-2 and to the reported KMNADHs of NDH-2 from other species (Figures 5B and 5C).5,8,13,32-
34 The maximum turnover rate was approximately 40% of that of C. thermarum NDH-2. Given 
the use of SMA-solubilized Listeria NDH-2, the estimation of the lipid-to-protein ratio in the 
proteoliposomes less certain, further experiments will be required to determine kcat (s−1). 
Immediately after NADH titration, we performed HQNO titration experiments using the same 
cell. Interestingly, HQNO showed weaker inhibition against Listeria NDH-2a than against C. 
thermarum NDH-2, with a maximum inhibition activity of approximately 38% (Figures 5D 
and S3C). The membrane anchoring domain of NDH-2 is the least conserved among the 
species (Figures S3A, S3D and S3E). Critically, two amino acids in the quinone-head group 
binding pockets differ between Listeria and C. thermarum NDH-2s (I320M and Y383A, amino 
acid numbers from C. thermarum NDH-2), which could alter its structural architecture and 
impact the HQNO binding affinity (Figure S3F). Together with observation that a I379E 
mutation of C. thermarum NDH-2 has a more pronounced effect in the electrochemical 
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membrane platform (see above), a membrane environment seems to accentuate effects of 
amino acid substitutions at the Q-site compared to in-solution. Furthermore and seen the 
dissimilarities of NDH-2 across different species, these results indicate that the developed new 
antimicrobials or anti-protozoal agents targeting NDH-2 might be narrow-spectrum. 
Conclusion
In summary, we built a novel bioelectrochemical platform to characterize the monotopic 
respiratory enzyme NDH-2 in a native-like lipid environment. This system has four major 
advantages over the conventional biochemical assay: (1) it allows both characterization of 
NDH-2 and assessment of inhibitors in close to physiological conditions (i.e., in-membrane), 
(2) it requires only a very small amount (< 0.45 pg) of active NDH-2, (3) it is versatile as shown 
by performance of inhibitor experiments after NADH titration and reuse of the electrochemical 
cell, and (4) the chemical properties of inhibitors in the membrane can be analyzed. 
Furthermore, our system is highly reproducible and stable for > 12 h with no reduction in 
activity.
Two NDH-2s from C. thermarum and L. monocytogenes EGD-e were successfully 
characterized. The membrane-bound NDH-2 follows Michaelis–Menten kinetics for both 
NADH and MK-7. Interestingly, we discovered that NDH-2 required a high quinone 
concentration (> 3 mM) to reach its full catalytic performance. This might imply the quinone 
concentration in the membrane is biologically important, and that the NADH-coupled 
respiratory activity in bacteria might be regulated by quinone availability in the membrane.
Unexpectedly, we discovered that a class of promising anti-tubercular agents, phenothiazines, 
have novel effects. Cyclic voltammetry and impedance spectroscopy of the bioelectrochemical 
platform, together with solution assays with liposomes encapsulating HPTS, indicate that CPZ 
can disrupt pH gradients across bacterial membranes. 
Materials and Methods
Chemicals
Escherichia coli polar phospholipid extract in chloroform (Avanti), menaquinone-7 
(FUJIFILM Wako), Ni-NTA Agarose Resin (Thermo Fisher Scientific), 8%–16% Mini-
PROTEAN TGX precast gels (Bio-Rad), and 2-heptyl-4-hydroxyquinoline-N-oxide (Santa 
Cruz Biotech) were purchased for use in this study. Chlorpromazine, trifluoperazine, 
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thioridazine, 6-mercapto-1-hexanol (99%), ubiquinone-10 and 8-hydroxypyrene-1,3,6-
trisulfonic acid were purchased from Sigma–Aldrich. The styrene maleic anhydride polymer 
XIRAN SL30010 P20 was kindly provided by Polyscope. 
Caldalkalibacillus thermarum NDH-2 and Listeria monocytogenes EGD-e NDH-2a 
(lmo2389) expression constructs
In previous studies, we used a C. thermarum NDH-2 with a hexahistidine tag at its C-terminus 
for in-solution biochemical and biophysical studies.6,8,26,45 However, this tag was linked 
immediately after two amphipathic α-helices that are anchored to the membrane,6,45 which 
potentially compromised the binding ability of C. thermarum NDH-2 to the membrane. The 
N-terminus of C. thermarum NDH-2 is exposed to the cytosol and physically distant from the 
membrane interface. Therefore, we switched the hexahistidine tag to the N-terminus. PCR was 
performed as previously described except the primers N-Hisndh2F (5’-
AAATTTCCATGGGCCACCATCACCATCACCATAGCAAACCAAGCATTGTG-3’) and 
N-Hisndh2R (5’-AAATTTGTCGACTCAAAAACGCCCTTTTTTCAA-3’) were used to 
amplify the C. thermarum ndh-2 gene with an additional hexahistidine tag at its N-terminus.6 
The PCR product was cloned into pTRC99a as previously described.6 G164E and I379E 
variants were also constructed similarly except templates constructed in previous work were 
used.8
To clone a L. monocytogenes EGD-e ndh-2a (lmo2389), PCR was performed using L. 
monocytogenes EGD-e genomic DNA as a template and a primer set of lmo2389-N-HisF (5’-
AAAAAACCATGGGTCACCATCACCATCACCATAAACCAAAAATTGTCATTCTCG
GAGCAG-3’) and lmo2389-N-HisR (5’-
AAAAAAGTCGACTCATTTATAGAATTTGAATTTACCTTTACTTGCCAAGACGC-3’). 
PCR mix containing PhusionTM DNA polymerase was prepared according to the 
manufacturer’s recommendations (FINNZYMES). The initial denaturation step was for 5 min 
at 95 °C, followed by 35 cycles of amplification (30 s at 95 °C, 30 s at 55 °C, and 1 min at 
72 °C). A final extension step was carried out at 72 °C for 10 min. PCR products of the L. 
monocytogenes EGD-e ndh-2a gene were digested using the restriction enzymes NcoI and SalI, 
and then cloned into pTRC99a. The resulting expression construct was named pTRC99a-N-
Hisndh-2a.
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Expression and purification of C. thermarum NDH-2 and L. monocytogenes EGD-e NDH-
2a
Caldalkalibacillus thermarum NDH-2 was expressed and purified as described previously.6 In 
the size-exclusion purification step, similar concentrations of wild-type, G164E, and I379E 
NDH-2 variants were loaded on the column so that the fractions had similar protein 
concentrations. All variants were eluted from the column in a very similar manner. After the 
fractions were analyzed by SDS-PAGE, samples were pooled and concentrated. All variant 
samples had similar protein and detergent concentrations. Glycerol (10%, w/v) was added to 
the concentrated samples, and the samples (final protein concentration of 4 mg mL−1) were 
flash-frozen in liquid nitrogen and stored at −80 °C. Of note, switching the tag did not affect 
the catalytic activity of NDH-2. The specific activity was measured as previously described in 
the presence of 200 μM NADH and 400 μM MD at 37 C.8,26 The activity of the N-terminally 
histidine-tagged C. thermarum wild-type NDH-2 was 980 s−1 and consistent with that 
measured for the C-terminally histidine-tagged C. thermarum wild-type NDH-2.8,26
For over-expression of L. monocytogenes EGD-e NDH-2a, E. coli C41 (DE3) cells46 were 
transformed using a pTRC99a-N-Hisndh-2a expression construct. To express Listeria NDH-
2a, transformed E. coli were inoculated into 800 mL of LB media containing 100 μg mL−1 
ampicillin and grown at 37° C and 200 rpm to reach an OD600 of approximately 0.6–0.7. After 
cooling the cell culture at 4 °C for 10 min, isopropyl-β-D-thiogalactopyranoside (final 
concentration of 0.5 mM) was added and the cell culture was incubated at 18 °C and 200 rpm. 
Approximately 1 day later, the OD600 of the cell culture reached 1.9–2.0. Cells were harvested 
by centrifugation and the cell pellets were stored at −80 °C. 
To extract E. coli membrane containing over-expressed Listeria NDH-2a, 80 mL of lysis buffer 
(50 mM Tris pH 7.5 containing 2 mM MgCl2) was added to the pellet obtained from the 1-L 
culture. The resuspended cells were French pressed twice at 10000 psi. The cell lysate was 
subjected to centrifugation at 8000 g, 4 °C for 15 min. The obtained supernatant was subjected 
to ultracentrifugation at 146000 g, 4°C for 1 h to isolate the E. coli membrane. The harvested 
membrane was flash-frozen in liquid nitrogen and stored at −80 °C.
To purify Listeria NDH-2a, a SMA polymer method was employed.44 The membrane was 
resuspended in Buffer A (50 mM Tris buffer, pH 8.0, containing 500 mM NaCl and 10% (v/v) 
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glycerol) to give a final membrane concentration of 80 mg mL−1. Then, 5% (w/v) SMA buffer 
(50 mM Tris buffer, pH 8.0, containing 500 mM NaCl, 10% (v/v) glycerol and 5% (w/v) 
XIRAN SL30010 P20) was added to give a final membrane concentration of 40 mg mL−1 and 
SMA (XIRAN SL30010 P20) content of 2.5% (w/v). The resulting sample was incubated at 
room temperature for 2 h with gentle agitation. The insoluble fraction was removed by 
centrifugation at 100000 g, 4 °C for 45 min. Ni-NTA resin equilibrated with Buffer A was 
added to the supernatant (1-mL resin bed volume to 1 g of membrane) and incubated at 4 °C 
overnight with gentle agitation. The sample was transferred to an Econo-Column (Bio-Rad) 
and the unbound fraction was collected. The resin was first washed with Buffer A and then 
washed with Buffer A containing 10 mM imidazole. The bound Listeria NDH-2a was eluted 
using Buffer A containing 300 mM imidazole. The fractions were analyzed by SDS-PAGE. 
The 300 mM imidazole fraction was buffer exchanged with 50 mM Tris buffer (pH 8.0, 
containing 150 mM NaCl) and the sample was concentrated to 3 mg mL−1. Finally, the sample 
was flash-frozen in liquid nitrogen and stored at −80 °C.
Reconstitution of C. thermarum NDH-2 and Listeria NDH-2a in an E. coli polar lipid 
proteoliposome
An established extrusion protocol was used for proteoliposome reconstitution with a 
modification to use 200-nm nucleopore track-etched membrane (Whatman).35 For 
reconstitution of C. thermarum NDH-2, 5 mg of E. coli polar lipid, 50 μg of MK-7/ubiquinone-
10 (UQ-10), and 20 μg of purified C. thermarum NDH-2 were extruded into 1 mL of 20 mM 
MOPS–KOH buffer (pH 7.4, containing 30 mM K2SO4). For MK-7 titration experiments, 12.5, 
25, 37.5, 50, or 75 μg of MK-7 was incorporated. For reconstitution of Listeria NDH-2a, 5 mM 
MgCl2 (final concentration) was added to 60 μg of SMA purified Listeria NDH-2a and the 
mixture was incubated at room temperature for 30 min to remove SMA.47 The supernatant was 
obtained after centrifugation at 17000 g for 3 min. Then, 5 mg of E. coli polar lipid, 50 μg of 
MK-7, and 15 μg of MgCl2-treated Listeria NDH-2a sample were extruded into 1 mL of 20 
mM MOPS–KOH buffer (pH 7.4, containing 30 mM K2SO4) for reconstitution of Listeria 
NDH-2a in proteoliposome. 
Establishing a tethered bilayer lipid membrane containing C. thermarum NDH-2 and 
Listeria NDH-2a
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The electrochemical set-up is described elsewhere.35 An Autolab (Eco-chemie) 
electrochemical analyzer equipped with a PGSTAT128N potentiostat, SCAN250 module, and 
FRA32M frequency analyzer was employed for electrochemical measurements with a 
Ag/AgCl (sat. KCl) reference electrode from Radiometer. All potentials are quoted versus the 
standard hydrogen electrode (SHE, ESHE = EAg/AgCl + 0.199 V). The electrochemical cell was 
housed in a Faraday cage to minimize noise. Oxygen-free argon gas was bubbled into the cell 
solution at the constant flow rate. The cell solution was constantly mixed using a stir bar during 
cyclic voltammetry experiments to reduce mass diffusion effects of NADH. All impedance 
spectra were measured at 0.199 V vs SHE.
The SAM and tethered bilayer lipid membrane (tBLM) were assembled as described 
previously.35 A SAM consisting of 45%–60% EO3-cholesterol and 55%–40% 6-mercapto-1-
hexanol was used in this study and the composition of the SAM was checked with impedance 
spectroscopy before each experiment, as described.35 A 1.78-mL aliquot of 20 mM MOPS–
KOH buffer (pH 7.4, containing 30 mM K2SO4) was added to the cell, and 200 μL of 
proteoliposomes containing either C. thermarum NDH-2 or Listeria NDH-2a was applied in 
the presence of 10 mM CaCl2. We note that C. thermarum NDH-2 could be directly 
immobilized on a tBLM by adding a purified NDH-2 sample to the electrochemical cell; 
however, we discovered the quantity of immobilized C. thermarum NDH-2 varied largely 
between experiments with this latter method and hence preparing proteioliposomes prior to 
tBLM formation was preferred. Formation of the tBLM was verified by monitoring the 
decrease in double-layer capacitance using an electrochemical impedance spectroscopy.35 
After preparing the tBLM, the cell was first washed with 1 mM EDTA and then thoroughly 
washed with 20 mM MOPS–KOH buffer pH 7.4, containing 30 mM K2SO4. The integrity of 
the tBLM–SAM system was checked after washing and throughout the experiments by 
electrochemical impedance spectroscopy.
Electrochemical NDH-2 assay.
All electrochemical experiments were performed with 2 mL of 20 mM MOPS–KOH buffer pH 
7.4, containing 30 mM K2SO4 in the cell. The experiments were performed at 20 °C in either 
duplicate or triplicate. For the NADH oxidation assay, cyclic voltammograms were recorded 
between −0.401 and 0.449 V at a scan rate of 10 mV s−1. MK-7 reduction and oxidation peaks 
were typically observed at around −0.30 and 0.15 V, respectively. Escherichia coli polar lipid 
extract contains a trace amount of UQ-8, which gave reduction and oxidation peaks at around 
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−0.10 and 0.35 V, respectively. Using UQ-10, cyclic voltammograms were recorded between 
−0.201 and 0.599 V at a scan rate of 10 mV s−1. A molar concentration of membrane-
incorporated MK-7 was estimated after integrating the MK-7 oxidation peak area to calculate 
the surface coverage (pmol cm-2),48 which was divided by the thickness of lipid membrane 
(4nm). For the NADH and NADPH titration experiments, the MK-7 concentration was fixed 
at 3-7 mM, and for the MK-7 titration experiments, the NADH concentration was fixed at 200 
μM. For the 2-heptyl-4-hydroxyquinoline-N-oxide and phenothiazine inhibitory assay, the 
NADH and MK-7/UQ-10 concentrations were fixed at 200 μM and 3-7 mM, respectively. 2 
and 10 mM stocks of inhibitors were prepared in dimethyl sulfoxide (HQNO) or in water 
(phenothiazines). After formation of the tBLM–SAM system containing NDH-2, these stock 
solutions were titrated to the solution in the electrochemical cells at end concentrations 
indicated in the Results section. 
Fluorescent liposome assay.
Fluorescent liposome assays were performed in 20 mM MOPS–KOH buffer (pH 7.4, 
containing 30 mM K2SO4) at 20 °C. First, HPTS was encapsulated inside the liposome lumen 
by rehydrating 5 mg of E. coli polar lipid extract in 0.5 mL of MOPS-KOH buffer containing 
5 mM HPTS and extruding the lipid suspension through 400-nm nucleopore track-etched 
membranes. Non-encapsulated HPTS was removed by size-exclusion chromatography in 
MOPS-KOH buffer using a Nap-5 G25 column (GE Healthcare) according to the 
manufacturer’s instructions. The liposomes with encapsulated HPTS were diluted to about 40 
µg mL−1 lipid in a cuvette and the ratiometric fluorescence was monitored in real-time by 
recording the emission at 510 nm as a ratio of excitations at 405 and 455 nm. At specific time 
points, the extravesicular pH was lowered by addition of a small amount of 1 M HCl, followed 
by addition of either 4 µM gramicidin or 100 µM CPZ (end concentrations). A calibration 
curve (ratiometric fluorescence vs known pH) of HPTS in MOPS-KOH buffer was used to 
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Figure 1. New bioelectrochemical platform for analysis of the monotopic membrane 
protein NDH-2 in the membrane environment. (A) Schematic diagram of C. thermarum 
NDH-2 bound on the tethered bilayer lipid membrane, which is self-immobilized on a self-
assembled monolayer made of a mixture of 6-mercapto-1-hexanol and a cholesterol ‘tether’ (a 
cholesterol linked to a thiol group via a short ethylene-glycol chain). NDH-2 oxidizes NADH 
in the aqueous phase, while quinone is reduced and re-oxidized in the lipid phase on the gold 
surface. Molecules of NAD+, FAD, and the quinone are shown in yellow, purple, and green, 
respectively. (B) Cole–Cole plots of real (Re) and imaginary (Im) admittances before (black) 
and after (red) applying proteoliposomes containing C. thermarum NDH-2. A drop in 
capacitance indicates formation of planar membrane. Another Cole–Cole plot checking 
membrane after the experiments in Figure 2A is shown in grey. 
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Figure 2. Steady-state electrochemical enzyme kinetics of C. thermarum NDH-2 bound on 
membrane. (A) Cyclic voltammogrames (CVs) recorded at various NADH concentrations (0 
(blue)–400 (red) M) for a wild-type NDH-2. Currents read at 0.3 V versus the standard 
hydrogen electrode (SHE) of the reductive scan were used in panel B. (B), (C), and (D) NADH, 
MK-7, and NADPH titration experiments for wild-type NDH-2, respectively. After the 
NADPH titration experiment, the electrochemical cell was washed and NADH was added to 
measure the activity (red). (E) and (F) NADH titration experiments for G164E and I379E 
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NDH-2 variants, respectively. The data were fitted to the Michealis–Menten equation, except 
for data in panel E. The data points and error bars are averages ± SEM from two or three 
technical replicates. 
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Figure 3. Electrochemical assays showing HQNO inhibits C. thermarum NDH-2 but 
phenothiazines do not. (A) Chemical structures of HQNO and phenothiazines tested in this 
study. (B) CVs recorded in the presence of 0 (red)–100 (green) M HQNO. Other HQNO 
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concentrations are shown in grey. A baseline CV (blue) in the absence of both NADH and 
HQNO is also shown. (C) HQNO inhibition curve. The C. thermarum NDH-2 activity in the 
absence of HQNO was taken as 100%. A variable slope model was fitted to determine the IC50 
value. (D) CVs recorded for CPZ experiments. CVs were recorded in the presence of 0 (red)–
100 (green) M CPZ. The MK-7 oxidation peak shift is shown with an arrow. (E) 
Phenothiazines do not inhibit C. thermarum NDH-2. The NDH-2 activity in the absence of 
phenothiazines was taken as 100%. All experiments were performed in the presence of 200 
M NADH and 3-7 mM MK-7, and in duplicate.
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Figure 4. Ionophore effects of CPZ. (A) CVs recorded with 0 (blue), 10, 30, 60, and 100 (red) 
M CPZ in the absence of NADH show clear shifts of MK-7 oxidation (ox) and reduction (re) 
peaks. Escherichia coli polar lipid extract contained a small amount of UQ-8. Shifts of UQ-8 
ox and re peaks are also evident. (B) Bode plots (+) and impedance (circles) before (black) and 
after (red) addition of 100 M CPZ. (C) Fluorescent liposome assays using 8-hydroxypyrene-
1,3,6-trisulfonic acid as a pH probe. Points of addition of 1 M HCl and ionophores are indicated 
with arrows. Experiments were conducted with gramicidin (black) and CPZ (red).
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Figure 5. Characterization of Listeria NDH-2a using the electrochemical NDH-2 assay 
platform. (A) Cole–Cole plots measured at 0 V versus the SCE before (black) and after (red) 
applying a proteoliposome containing Listeria NDH-2a. (B) CVs recorded with 0 (blue)–180 
(red) M NADH. Currents read at 0.3 V versus the SHE of the reductive scan are used in panel 
C. (C) Steady-state kinetic analysis of Listeria NDH-2a. The data were fit to the Michealis–
Menten equation. (D) HQNO does not inhibit Listeria NDH-2a efficiently. The Listeria NDH-2 
activity in the absence of HQNO was taken as 100%. All experiments were performed in the 
presence 3-7 mM MK-7. The data points and error bars are averages ± SEM from two or three 
technical replicates. 
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